Total Payments
$25,693
2024 Payments
$16,815
Companies
43
Transactions
610
Medicare Patients
4,054
Medicare Billing
$414,769
Payment Breakdown by Category
Food & Beverage$11,638 (45.3%)
Other$11,610 (45.2%)
Travel$2,403 (9.4%)
Education$41.28 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,638 | 592 | 45.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,740 | 3 | 30.1% |
| Honoraria | $3,870 | 1 | 15.1% |
| Travel and Lodging | $2,403 | 10 | 9.4% |
| Education | $41.28 | 4 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | $9,421 | 22 | $0 (2024) |
| Madrigal Pharmaceuticals | $5,255 | 13 | $0 (2024) |
| ABBVIE INC. | $2,511 | 147 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,271 | 91 | $0 (2024) |
| Celgene Corporation | $895.28 | 54 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $838.44 | 46 | $0 (2024) |
| Covidien LP | $782.67 | 5 | $0 (2018) |
| Gilead Sciences, Inc. | $491.78 | 17 | $0 (2024) |
| PFIZER INC. | $439.55 | 23 | $0 (2024) |
| Janssen Biotech, Inc. | $416.88 | 21 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16,815 | 136 | Phathom Pharmaceuticals, Inc. ($9,421) |
| 2023 | $1,792 | 105 | AbbVie Inc. ($438.12) |
| 2022 | $1,612 | 87 | ABBVIE INC. ($366.24) |
| 2021 | $976.30 | 58 | AbbVie Inc. ($350.82) |
| 2020 | $289.02 | 19 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($123.38) |
| 2019 | $1,009 | 55 | AbbVie, Inc. ($244.85) |
| 2018 | $2,043 | 80 | Covidien LP ($766.55) |
| 2017 | $1,157 | 70 | AbbVie, Inc. ($280.39) |
All Payment Transactions
610 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/10/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: LIVER DISEASE | ||||||
| 12/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/06/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: LIVER DISEASE | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $19.29 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.59 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $36.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/10/2024 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Biosimilars | ||||||
| 11/07/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 11/06/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,720.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $23.16 | General |
| 11/05/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Honoraria | Cash or cash equivalent | $3,870.00 | General |
| Category: LIVER DISEASE | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Iron Deficiency Anemia | ||||||
| 10/31/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $8.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/26/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Travel and Lodging | In-kind items and services | $695.88 | General |
| Category: LIVER DISEASE | ||||||
| 10/26/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Travel and Lodging | Cash or cash equivalent | $201.00 | General |
| Category: LIVER DISEASE | ||||||
| 10/26/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Travel and Lodging | Cash or cash equivalent | $136.00 | General |
| Category: LIVER DISEASE | ||||||
| 10/26/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $87.89 | General |
| Category: LIVER DISEASE | ||||||
| 10/26/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | Cash or cash equivalent | $40.42 | General |
| Category: LIVER DISEASE | ||||||
| 10/26/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | Cash or cash equivalent | $15.34 | General |
| Category: LIVER DISEASE | ||||||
| 10/25/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | Cash or cash equivalent | $101.02 | General |
| Category: LIVER DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,012 | 1,113 | $672,762 | $102,239 |
| 2022 | 9 | 1,056 | 1,142 | $771,714 | $112,306 |
| 2021 | 10 | 975 | 1,074 | $667,632 | $96,475 |
| 2020 | 12 | 1,011 | 1,133 | $533,425 | $103,749 |
Total Patients
4,054
Total Services
4,462
Medicare Billing
$414,769
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 127 | 130 | $190,970 | $27,574 | 14.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 203 | 246 | $57,889 | $23,059 | 39.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 259 | 288 | $47,791 | $18,580 | 38.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 200 | 205 | $229,190 | $15,277 | 6.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 106 | 119 | $100,436 | $8,292 | 8.3% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 30 | 30 | $33,030 | $3,979 | 12.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $9,762 | $3,731 | 38.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $2,246 | $952.07 | 42.4% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 44 | 52 | $1,449 | $795.60 | 54.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 145 | 147 | $215,943 | $30,123 | 13.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 207 | 247 | $58,124 | $23,212 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 217 | 241 | $39,992 | $15,264 | 38.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 211 | 215 | $240,370 | $14,612 | 6.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 152 | 166 | $140,104 | $11,201 | 8.0% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2022 | 11 | 11 | $17,647 | $7,163 | 40.6% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2022 | 41 | 43 | $47,343 | $5,824 | 12.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 37 | 37 | $11,274 | $4,358 | 38.7% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2022 | 35 | 35 | $917.90 | $548.24 | 59.7% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 108 | 110 | $161,590 | $22,974 | 14.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 232 | 274 | $44,024 | $18,316 | 41.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 154 | 170 | $38,287 | $15,410 | 40.2% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 174 | 177 | $197,886 | $12,134 | 6.1% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope using a mechanical snare | Facility | 2021 | 55 | 56 | $61,656 | $7,402 | 12.0% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 127 | 137 | $115,628 | $6,829 | 5.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 39 | 39 | $11,704 | $4,801 | 41.0% |
About Dr. Dawei Yang, MD
Dr. Dawei Yang, MD is a Gastroenterology healthcare provider based in Frederick, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922087477.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dawei Yang, MD has received a total of $25,693 in payments from pharmaceutical and medical device companies, with $16,815 received in 2024. These payments were reported across 610 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($11,638).
As a Medicare-enrolled provider, Yang has provided services to 4,054 Medicare beneficiaries, totaling 4,462 services with total Medicare billing of $414,769. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Frederick, MD
- Active Since 01/12/2006
- Last Updated 11/07/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1922087477
Products in Payments
- VOQUEZNA (Drug) $9,421
- REZDIFFRA (Drug) $5,207
- ZEPOSIA (Drug) $983.53
- TRULANCE (Drug) $610.46
- XIFAXAN (Drug) $594.12
- Humira (Biological) $565.93
- DUPIXENT (Biological) $520.87
- LINZESS (Drug) $516.60
- Manometry (Device) $440.16
- XELJANZ (Drug) $439.55
- RINVOQ (Biological) $415.18
- HUMIRA (Biological) $373.10
- GATTEX (Drug) $328.56
- ENTYVIO (Biological) $319.86
- OCALIVA (Drug) $317.02
- STELARA (Biological) $305.31
- Entyvio (Biological) $276.52
- DIFICID (Drug) $259.13
- Trulance (Drug) $201.05
- Creon (Drug) $190.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Frederick
Dr. Sanmeet Singh, M.d, M.D
Gastroenterology — Payments: $16,690
Gastroenterology $16,690
Dr. Moustafa Ahmed, M.d, M.D
Gastroenterology — Payments: $11,949
Gastroenterology $11,949
Dr. Leonard Kane, M.d, M.D
Gastroenterology — Payments: $10,857
Gastroenterology $10,857
Dr. Ali Husain, Md, MD
Gastroenterology — Payments: $9,370
Gastroenterology $9,370
Dr. Hemant Chatrath, M.d, M.D
Gastroenterology — Payments: $8,119
Gastroenterology $8,119
Dr. Sean Hunt, M.d, M.D
Gastroenterology — Payments: $7,682
Gastroenterology $7,682